|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.20/-1.72
|
企业价值
2.48B
|
资产负债 |
每股账面净值
12.65
|
现金流量 |
现金流量率
--
|
损益表 |
收益
8.08M
|
每股收益
0.16
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/16 10:27 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer. |